Feb. 05, 2021
FILE NO S7-24-20 My name is Alexanderia Blankenship and I have been Chief Executive Officer of AngioSoma, Inc. (OTC: SOAN) since April 2016. We have been a very active company in the medical and supplement space and, I hope, a contribution to the growing number of female managed public companies. After the number of years I have run this company with characteristic success and failure, we would not be financially alive or in business if not for the reliable and dependable support of Power Up Lending Group. If the proposed amendment to Rule 144 is adopted, Power Up will no longer be able to support AngioSoma and we will close the doors and write off the 5 years of investment by many people who have devoted their time and money to the success of SOAN. Sincerely, Alex Alex K. Blankenship President/CEO AngioSoma, Inc.